Beyond is an Australian privately owned early phase CRO and drug development consultancy dedicated to early-stage product development. Our focus is primarily on advancing innovative products from small to medium biotechnology and pharmaceutical companies worldwide by utilizing the advantages the Australia region provide (such as the Australian Research and Development Tax Incentive) to eligible companies in conducting R and D in the region.

As an Australian privately owned early phase CRO, we provide flexible and nimble solutions to match the needs of our clients, whether it is a stand-alone activity or a full suite of services.​

The Beyond Collective provides expert support with a team averaging 20 years experience in early phase product development, including preclinical consulting, guiding clients through product development post-discovery into the successful conduct of clinical trials in the Australia

With our global experience in Drug Development and the management of Early Phase Trials in the region, Beyond can provide creative and adaptive strategies to ensure you get where you need to be, from drug discovery through to market.